Action Point Financial Planning’s Boston Scientific BSX Stock Holding History

Action Point Financial Planning’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Buy	+361	New	+$19.6K	﹤0.01%	1257

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Action Point Financial Planning's BSX Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Boston Scientific (BSX) in Q2 2026: 361 shares worth $15.2K. The stake represents ﹤0.01% of the portfolio and ranks #1257 among its holdings.

1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Action Point Financial Planning held 361 shares of Boston Scientific worth $15.2K as of Q2 2026.
Boston Scientific was a new Action Point Financial Planning position in Q2 2026.
Boston Scientific made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #1257 holding.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.